ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to Include Patients 2-5 Years of Age
June 11, 2019PTC Therapeutics Receives FDA Approval for the Expansion of the Emflaza (deflazacort) Labeling to Include Patients 2-5 Years of Age. -
Duchenne drug poised to cost $35,000 but with major catch
May 10, 2017For those that have not followed the story, Emflaza was successfully taken through the FDA regulatory process by Marathon as the first new treatment for Duchenne muscular dystrophy. -
US FDA approves Emflaza tablets to treat patients with DMD
February 14, 2017The US Food and Drug Administration (FDA) has approved Emflaza (deflazacort) tablets and oral suspension to treat patients with Duchenne muscular dystrophy (DMD). -
FDA Approves Emflaza
February 10, 2017FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy
Pharma Sources Insight January 2025
